Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Expanding the Case for Hybrid Insulin Peptides in Type 1 Diabetes.
Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study.
See All 2 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Expanding the Case for Hybrid Insulin Peptides in Type 1 Diabetes.
Cerosaletti K, Kent SC. Expanding the Case for Hybrid Insulin Peptides in Type 1 Diabetes. Diabetes. 2025 Jun 01; 74(6):870-872.
View in:
PubMed
authors with profiles
Sally C Kent PhD